论文部分内容阅读
目的探讨腹水回输连接血液透析治疗特发性尿毒症顽固性腹水(IUA)的疗效。方法收集近年来我院血液净化中心诊断的10例IUA的临床资料,根据是否接受血透过程中腹水回输治疗将其分为腹水回输组和非腹水回输组,并结合文献进行分析。结果与非腹水回输组相比,腹水回输组接受的血滤过程中腹水回输治疗对消除腹水,改善低蛋白血症有益。结论腹水回输连接血液透析治疗能使腹水中蛋白成分回输入血,提高患者血中胶体渗透压,增加患者对超滤脱水的耐受力,减少腹水,对特发性尿毒症性腹水有明显疗效。
Objective To investigate the efficacy of ascites reinfusion in the treatment of idiopathic uremic refractory ascites (IUA) by hemodialysis. Methods The clinical data of 10 cases of IUA diagnosed by our hospital’s blood purification center in recent years were collected and divided into two groups according to whether they were transfused ascites fluid during hemodialysis or not. Results Compared with the non-ascites transfusion group, the ascites transfusion therapy in the ascites transfusion group was beneficial to eliminate ascites and improve hypoproteinemia. Conclusions The treatment of hemodialysis with ascites reinfusion can bring the protein components in ascites back into the blood, increase the colloid osmotic pressure in the blood, increase the patient’s resistance to ultrafiltration and dehydration, reduce the ascites, and have obvious effect on idiopathic uremic ascites Efficacy.